| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2138453 | Leukemia Research | 2010 | 5 Pages |
Abstract
Background/AIMSLymphoma-specific gene expression in peripheral blood reflects the presence of circulating lymphoma cells (CLCs). MAGE-A3 is widely expressed in solid tumors and is a potent candidate for immunotherapy. To determine whether MAGE-A3 expression would be a useful marker for CLCs in non-Hodgkin lymphoma (NHL), we assessed MAGE-A3 mRNA expression in the peripheral blood of NHL patients and controls.MethodsWe measured MAGE-A3
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Mi Hwa Han, Hyeon-Seok Eom, Weon-Seo Park, Tak Yun, Sohee Park, Hyun-Ju Kim, Chang-Ho Jeon, Sun-Young Kong,